Joseph C. Scodari

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New Brunswick, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Kostantinos Skordalos, Power of Attorney For: Joseph C. Scodari
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Joseph C. Scodari

Form 4 holding Director

OptiNose, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
32,000
Estimated value
Report date
08 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Acurx Pharmaceuticals, Inc.

Security class
Warrants for Common Stock
Shares / value
24,631
Estimated value
Report date
06 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Acurx Pharmaceuticals, Inc.

Security class
Stock Option
Shares / value
12,000
Estimated value
Report date
17 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Joseph C. Scodari

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .